CD274 and neoplasm: The poor response to anti-PD-1/PD-L1 monotherapy and the well-known characteristic of this tumor of having a highly immunosuppressive tumor microenvironment suggested that the effectiveness of combined chemo-immunotherapy needed to be explored.